These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8467641)

  • 1. Nonparametric estimation of potency ratio for dilution assays.
    Moussa MA
    Comput Biol Med; 1993 Jan; 23(1):77-82. PubMed ID: 8467641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioassay from two parabolas.
    Moussa MA
    Comput Biol Med; 1993 Jan; 23(1):69-76. PubMed ID: 8467640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-parametric interval estimation of relative potency for dilution assays, including the case of non-monotone dosage response curves.
    Mantel N; Schneiderman MA
    Biometrics; 1975 Sep; 31(3):619-32. PubMed ID: 1174621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative test for trend in exposure-response analysis.
    Dosemeci M; Benichou J
    J Expo Anal Environ Epidemiol; 1998; 8(1):9-15. PubMed ID: 9470101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A personal computer-based system for parallel line analysis of bioassay data.
    Iznaga N; Núñez G; Solozabal J; Morales A; Artaza E; Rubio R; Cardenas E
    Comput Methods Programs Biomed; 1995 Jul; 47(2):167-75. PubMed ID: 7587163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Lack-of-Fit Assessment as a System Suitability Test for Potency Assays.
    Li R; Cai W; Zocher M
    PDA J Pharm Sci Technol; 2017; 71(5):368-378. PubMed ID: 28624777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk analysis in cohort studies with heterogeneous strata. A global chi2-test for dose-response relationship, generalizing the Mantel-Haenszel procedure.
    Ahlborn W; Tuz HJ; Uberla K
    Methods Inf Med; 1990 Mar; 29(2):113-21. PubMed ID: 2342429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric Bayesian methods for benchmark dose estimation.
    Guha N; Roy A; Kopylev L; Fox J; Spassova M; White P
    Risk Anal; 2013 Sep; 33(9):1608-19. PubMed ID: 23339666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Different Estimation Methods for Accuracy and Precision in Biological Assay Validation.
    Yu B; Yang H
    PDA J Pharm Sci Technol; 2017; 71(4):297-305. PubMed ID: 28416644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International collaborative study by in vitro bioassays of the first international standard for porcine inhibin.
    Gaines Das RE; Rose M; Zanelli JM
    J Reprod Fertil; 1992 Nov; 96(2):803-14. PubMed ID: 1339860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and estimation in the limiting dilution assay when concentrations vary widely among samples.
    Parrish RS; Hazlett LJ
    J Biopharm Stat; 2000 May; 10(2):197-215. PubMed ID: 10803725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of bioassays for quality control.
    Lansky D
    Dev Biol Stand; 1999; 97():157-68. PubMed ID: 10463541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab.
    Prior S; Hufton SE; Fox B; Dougall T; Rigsby P; Bristow A;
    MAbs; 2018 Jan; 10(1):129-142. PubMed ID: 28985159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate bioassay.
    Vølund A
    Biometrics; 1980 Jun; 36(2):225-36. PubMed ID: 6996751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model-free approach to estimation of relative potency in dose-response curve analysis.
    Guardabasso V; Rodbard D; Munson PJ
    Am J Physiol; 1987 Mar; 252(3 Pt 1):E357-64. PubMed ID: 3826362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega.
    Meager A; Gaines Das R; Zoon K; Mire-Sluis A
    J Immunol Methods; 2001 Nov; 257(1-2):17-33. PubMed ID: 11687235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting specifications for potency assays--basic principles.
    Mire-Sluis AR
    Dev Biol (Basel); 2002; 107():107-15. PubMed ID: 12079184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric analysis of statistic images from functional mapping experiments.
    Holmes AP; Blair RC; Watson JD; Ford I
    J Cereb Blood Flow Metab; 1996 Jan; 16(1):7-22. PubMed ID: 8530558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?
    Wohlfarth K; Sycha T; Ranoux D; Naver H; Caird D
    Curr Med Res Opin; 2009 Jul; 25(7):1573-84. PubMed ID: 19463043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.